Serum Phosphate and the Risk of New-Onset Hyperuricemia in Hypertensive Patients

Autor:	Lishun Liu, Jianping Li, Jingjing Cao, Chengzhang Liu, Xiaobin Wang, Genfu Tang, Xiping Xu, Yimin Cui, Qinqin Li, Yun Song, Chongfei Jiang, Jingping Zhang, Yan Zhang, Binyan Wang, Xianhui Qin, Yong Huo
Rok vydání:	2019
Předmět:	Male China medicine.medical_specialty Homocysteine Comorbidity Hyperuricemia 030204 cardiovascular system & hematology Risk Assessment Severity of Illness Index Phosphates New onset 03 medical and health sciences chemistry.chemical_compound Sex Factors 0302 clinical medicine Double-Blind Method Internal medicine Confidence Intervals Odds Ratio Internal Medicine medicine Humans 030212 general & internal medicine Aged Retrospective Studies business.industry Incidence Age Factors nutritional and metabolic diseases Serum phosphate Middle Aged Prognosis medicine.disease Uric Acid Endocrinology chemistry Hypertension Uric acid Female business Biomarkers
Zdroj:	Hypertension. 74:102-110
ISSN:	1524-4563 0194-911X
DOI:	10.1161/hypertensionaha.119.12633
Popis:	The relationship of serum phosphate and new-onset hyperuricemia remains uncertain. We aimed to evaluate the relationship of serum phosphate with the risk of new-onset hyperuricemia, and to examine any possible effect modifiers in hypertensive patients. This is a post hoc analysis of the Uric Acid substudy of the CSPPT (China Stroke Primary Prevention Trial). A total of 10 612 participants with normal uric acid levels (
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7217695eff740a439f8cc21ebf756da8 https://doi.org/10.1161/hypertensionaha.119.12633 Zobrazit plný text záznamu